Stay updated on Relatlimab Safety in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Safety in B-Cell Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic UI/layout adjustments that do not modify the study details, inclusion/exclusion criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T02:41:36.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Added a government funding and operating-status notice (impactful; affects reliability and user expectations). - Updated software version to v3.2.0 (administrative change). - Removed the specific term 'B-cell chronic lymphocytic leukemia' (removal of a medical term; less impactful unless the page was about diseases).
    Difference
    3%
    Check dated 2025-10-06T15:58:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T09:53:17.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-15T00:16:56.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T20:44:27.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has added significant information regarding Hodgkin lymphoma and related diseases, including new resources and a detailed citation of a relevant study, while removing some previous location details and references to other diseases.
    Difference
    6%
    Check dated 2025-08-31T12:56:40.000Z thumbnail image

Stay in the know with updates to Relatlimab Safety in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.